From Conquering COVID-19 to Curing Cancer, New York City Charts the Future of Life Sciences

For the past 25 years, the public and private sectors have worked together to establish New York City as a global leader in life sciences research and innovation. Thanks to that coordinated effort, the city was able to respond to COVID-19 efficiently and effectively, becoming a model for other urban areas as COVID-19 cases peaked across the U.S.—and showcasing a burgeoning life sciences industry in the city that’s poised for future growth… New York life sciences companies continue to step up with solutions to the ongoing COVID-19 pandemic. They include Xylyx Bio, a Columbia University spinout that’s inventing drug-testing platforms made from biomaterials that mimic specific organs and tissues in the human body. Read more >>